Effects of interleukin 2 therapy on lymphocyte magnesium levels

Journal of Laboratory and Clinical Medicine

Volumn 139, Issue 1, 2002, Pages 5-12

  McKee, Mark D ^a   Cecco, Stacey A ^a   Niemela, Julie E ^a   Cormier, Janice ^a   Kim, Christina J ^a   Steinberg, Seth M ^a   Rehak, Nadja N ^a   Elin, Ronald J ^a   Rosenberg, Steven A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MAGNESIUM;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LYMPHOCYTE; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERLEUKIN-2; KIDNEY NEOPLASMS; LYMPHOCYTES; MAGNESIUM; MALE; MIDDLE AGED;

EID: 0036008992     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.120361     Document Type: Article

References (47)

1. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma
2. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
3. Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer
4. The neuropsychiatric effects of the treatment with interleukin-2 and lymphokine activated killer cells
5. Hematologic effects of immunotherapy with lymphokine activated killer cells and recombinant interleukin-2 in cancer patients
6. Interleukin-2 induces profound reversible cholestasis: A detailed analysis in treated cancer patients
7. Cardiorespiratory effects of immunotherapy with interleukin-2
8. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock
9. Metabolic and renal effects of interleukin-2 immunotherapy for metastatic cancer
10. Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: An interim report
11. Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer
12. Interleukin-2 based home therapy of metastatic renal cell carcinoma: Risks and benefits in 215 consecutive single institution patients
13. Functional, biochemical, and histopathologic consequences of high-dose interleukin-2 administration in rats
14. Effects of interleukin-2 immunotherapy on renal function
15. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks
16. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus
17. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia
18. Magnesium content and concentration of mononuclear and T lymphocyte blood cells
19. An analysis of variance test for normality (complete samples)
20. A sharper Bonferroni procedure for multiple tests of significance
21. Magnesium: The fifth but forgotten electrolyte
22. Red blood cell magnesium and chronic fatigue syndrome
23. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin
24. Magnesium deficiency: Pathophysiologic and clinical overview
25. Magnesium content of mononuclear blood cells
26. Comparison of two methods for determination of magnesium concentration of mononuclear blood cells
27. Fundamental issues for the interpretation of cellular magnesium
28. Determination of magnesium in granulocytes
29. Regulation of cellular magnesium
30. Regulation of magnesium efflux from rat spleen lymphocytes
31. Regulation of cell magnesium
32. Magnesium in cell proliferation and differentiation
33. Changes in free cytoplasmic magnesium following activation of human lymphocytes
34. Separate roles for calcium and magnesium in their synergistic effect on uridine uptake by cultured cells: Significance for growth control
35. Major intracellular cations and growth control: Correspondence among magnesium content, protein synthesis, and the onset of DNA synthesis in BALB/c3T3 cells
36. The requirements for ionized calcium and magnesium in lymphocyte proliferation
37. The role of magnesium in nucleic-acid and protein metabolism
38. Effects of interleukin-1 and gamma interferon on total intracellular magnesium concentration in a murine lymphoid cell line
39. Intracellular magnesium movements and lymphocyte activation
40. Ligand binding to integrins
41. Adhesion of human neutrophils to and activation by type-I collagen involving a beta 2 integrin
42. Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells
43. Integrin alpha1beta1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen
44. Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+
45. Reversible inactivation of purified leukocyte integrin CR3 (CD11b/CD18, alpha m beta 2) by removal of divalent cations from a cryptic site
46. Infectious complications associated with interleukin-2 administration: A retrospective review of 935 treatment courses
47. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy